Assessment of the Memory Immune Response, Safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV and Long-Term Follow-Up [EXTENSION OF 700036896]
Phase of Trial: Phase III
Latest Information Update: 09 Jan 2018
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Varicella zoster virus vaccine live
- Indications Chickenpox; Japanese encephalitis
- Focus Pharmacodynamics
- Sponsors Sanofi
- 09 Jan 2018 Results assessing 5-Year Antibody Persistence, published in the Journal of Infectious Diseases
- 05 Jul 2016 Status changed from active, no longer recruiting to completed.
- 01 Apr 2014 Planned End Date changed from 1 May 2016 to 1 Jun 2016 as reported by ClinicalTrials.gov record.